MichaelJClare-SalzlerMD

PubMed

• 7 citations
  The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.
  Kimberly J. Newsom, Yuan Zhang, Srikar Chamala, Katherine A. Martinez, Michael J. Clare-Salzler
  Journal of Clinical Laboratory Analysis. 2021-07-02
• 8 citations
  Predictors of oxylipins in a healthy pediatric population.
  Teresa Buckner, Lauren A. Vanderlinden, Randi K. Johnson, Brian C. DeFelice, Patrick M. Carry
  Pediatric Research. 2021-05-01
• 15 citations
  The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
  Teresa Buckner, Lauren A. Vanderlinden, Brian C. DeFelice, Patrick M. Carry, Katerina Kechris
  Diabetologia. 2021-04-24

Journal Articles

• A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history  
  Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type Diabetes TrialNet Study ..., Diabetes Care, 1/1/2015
• Racial-ethnic disparities in management and outcomes among children with type 1 diabetes  
  Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network, Pediatrics, 1/1/2015
• The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months  
  Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Pre..., Diabetes Care, 1/1/2015
• Autologous Umbilical Cord Blood Infusion Followed by Oral Docosahexaenoic Acid and Vitamin D Supplementation for C-Peptide Preservation in Children with Type 1 Diabetes  
  Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA, Biol Blood Marrow Transplant, 1/1/2013
• The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation  
  Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE; Pharmacogenomics Research Network Translational Phar..., Clin Pharmacol Ther, 1/1/2013
• Anti-lymphocyte antibody-based immunotherapy in type 1 diabetes  
  Xia CQ, Liu YT, Guan QB, Clare-Salzler M, Chin Med J (Engl), 1/1/2013
• Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials  
  Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, S..., Lancet, 1/1/2013
• The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis  
  Diabetes Research in Children Network (DirecNet) Study Group; Type 1 Diabetes TrialNet Study Group, Buckingham BA, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA,..., Diabetes Technol Ther, 1/1/2013
• Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry  
  Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, Bergenstal RM, Harris B, Dubose SN, Miller KM, Beck RW; T1D Exchange Clinic Network, J Clin Endocrinol Metab, 1/1/2013
• The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients  
  Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Pr..., Diabetes Care, 1/1/2013
• Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants  
  Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP Type 1 Diabetes TrialNet and Diabetes Prevention Trial–..., Diabetes, 1/1/2013
•  
  Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, DiMeglio LA, Bremer AA, Slover R, Tamborlane WV; Diabetes Research in Children Network (DirecNet) St..., Diabetes Care, 1/1/2013
• Institutional Profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics  
  Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR, Pharmacogenomics, 1/1/2013
• Rapamycin/IL-2 Combination Therapy in Patients with Type 1 Diabetes Augments Tregs yet Transiently Impairs beta-Cell Function  
  Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Blu..., Diabetes, 1/20/2012
• The T1D Exchange clinic registry  
  Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network, J Clin Endocrinol Metab, 1/1/2012
• Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies  
  Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; Type 1 Diabetes TrialNet Stud..., Diabetes Care, 1/1/2012
• Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice  
  Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-Dehoff RM, Wabitsch M, Clare-Salzler M, Atkinson M, PLoS One, 1/1/2012
• Performance of Glycated Hemoglobin (HbA1c) as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Typ..., Diabetes Care, 1/1/2012
• Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data  
  Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
• Antibacterial effects of zinc oxide nanorod surfaces  
  Jansson T, Clare-Salzler MJ, Zaveri TD, Mehta S, Dolgova NV, Chu BH, Ren F, Keselowsky BG, J Nanosci Nanotechnol, 1/1/2012
• Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array  
  Johnson JA, Burkley BM, Langaee TY, Clare-Salzler MJ, Klein TE, Altman RB, Clin Pharmacol Ther, 1/1/2012
• Pre-transplant myeloid dendritic cell deficiency associated with cytomegalovirus infection and death after kidney transplantation  
  Sun Q, Hall EC, Huang Y, Chen P, Dibadj K, Murawski M, Shraybman R, Van Kirk K, Tang V, Peng R, Patton PR, Clare-Salzler MJ, Kaplan B, Segev DL, Womer KL, Transpl Infect Dis, 1/1/2012
• Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice  
  Xia CQ, Chernatynskaya AV, Wasserfall CH, Wan S, Looney BM, Eisenbeis S, Williams J, Clare-Salzler MJ, Atkinson MA, BMC Immunol, 1/1/2012
• Total synthesis of grassystatin A, a probe for cathepsin E function  
  Yang S, Zhang W, Ding N, Lo J, Liu Y, Clare-Salzler MJ, Luesch H, Li Y, Bioorg Med Chem, 1/1/2012
• Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity:...  
  Miller MR, Yin X, Seifert J, Clare-Salzler M, Eisenbarth GS, Rewers M. Norris JM, Pediatric Diabetes, 1/24/2011
• Join now to see all

Books/Book Chapters

• Diabetes 1991: Proceedings of the 14th International Diabetes Federation Congress 
  Chapter: GAD autoimmunity in IDDM. 
  Kaufman, D.L. +. Erlander, M.D., Clare-Salzler, M., Atkinson, M., Maclaren, N.K., and Tobin A.J.Editors: H. Rifkin, J.A., Colwell, S.I. Taylor.Elsevier Science Publishers, Amsterdam1991

Abstracts/Posters

• STAT5 Dysfunction,GM-CSF Hyper-Responsiveness, & Aberrant Monocyte/Macrophage Prostaglanding Synthase 2 Expression in Type 1 Diabetes
  Litherland S.A., Peng R.H., Li, Y., Clare-Salzler, M.J, Keystone Symposium, 1/1/2002
• Defective Maturation of Myeloid Dendritic Cells (DC) in NOD Mice is controlled by IDD.
  Bahjat K, Li Y., Peng R.H., Clare-Salzler M.J., American Diabetes Association Meeting, Copper Mountain, CO, 1/1/2002
• Abnormalities in Peripheral Blood Dendritic Cell Populations in Type 1 Diabetes.
  Peng R.H., Li Y., Brezner K., Clare-Salzler M.J., American Diabetes Association Meeting, Copper Mountain, CO, 1/1/2002
• High-dose Indomethacin Does Not Cause Intestinal Damage in Infant Rats: What is the Mechanism?
  Manish, R., Patel, B.S., Clare-Salzler, M.J., 1/1/2001
• Increased Survival By Local Expression of Human Interleukin-10 In the Lymphnode in Murine Polymicrobial Sepsis.
  Oberholzer,O.A., LaFace, Clare-Salzler,M.J., Surgical Infection Society, 1/1/2001
• Dysfunctional GM-CSF-Mediated Transcriptional Regulation in Type 1 Diabetes & Pre-diabetic Human Monocytes & Nonobese Diabetic (MOD) Mouse Macrophages
  Litherland, S.A., Davoodi-Semironi A., Li. Y., Clare-Salzler, M.J., Keystone Symposium: Regulation of Immunity and Autoimmunity, 1/1/2001
• Aberrant Monocyte Prostaglandin Synthase 2 Activity in type 1 Diabetes Impairs T Cell IL2 Signaling and Activation Induced Cell Death.
  Litherland ,S.A., Whittaker, D., Bahjat, K.S., Peck, A.B., Clare-Salzer, M.J., Moldawer, L.L., Keystone Symposium, 1/1/2001
• Defective of Myeloid Dendritic Cells (DC) in NOD Mice is controlled in Part by Genes within the Idd10 Susceptibility Loci.
  Bahjat, K., Whittaker, D., Clare-Salzler, M.J., Keystone Symposium, 1/1/2001
• Type 1 Diabetic Monocyte Prostaglandin Synthase 2 Activity Impairs T Cell Activation Induced Cell Death by Suppressing IL2 Signaling
  Xie T.X., Litherland, S.A., Whittaker D.S., Bahjat K, Grebe, K.M., Selvaraj, L., Wasserfall, C., Peck, A.B., Moldawer, L.L., Clare-Salzler, M.J., FASEB/Experimental Biology/AAI Annual Meeting, 1/1/2001
• Malleability of autoimmune disease phenotypes.
  Mizutani A., Behney K.M., Litherland S.A., Clare-Salzler M., Richards H.B., Reeves W.H., American College of Rheumatology (ACR) 64th Annual Scientific meeting, Philadelphia, PA, 1/29/2000
• Genetic polymorphism in the response to lipopolysaccharide and D-galactosamine in the mouse.
  Bahjat F.R., Clare-Salzler, M.J., Moldawer L.L., Surgical Infection Society, 1/1/2000
• Prolonged GM-CSF activation of STAT5 in type 1 diabetes: Possible mechanism for aberrant prostaglandin synthase 2 (PGS2) expressions by autoimmune monocytes and macrop...
  Litherland S.A., Xie T., Davoodi-Semironi R., Schatz D., Clare-Salzler M.J., FASEB Summer Research Conference, 1/1/2000
• Genetic Determination of TNF Mediated Liver apoptosis.
  Bahjat, F.R., Clare-Salzler, M.J., Moldawer, L.L., 5th World Congress on Trauma, Shock, Inflammation and Sepsis, 1/1/2000
• Prostaglandin Synthase 2 expression as a risk assessment tolol fo IDDM: A new avenue for prevention and intervention?
  Litherland, S.A., Xie T., Muir A., Schatz D., She J-X., Atkinson M., Clare-Salzler M.J., Immunology of Diabetes Meeting Proceedings, 1/1/1999
• Prostaglandin Synthase 2 Expression as a Risk Assessment Tool for IDDM. A New Avenue for Prevention & Intervention?
  Litherland, S.A., Xie,T., Muir, A., Clare-Salzler, M.J., Immunology of Diabetes Society Proceedings, 1/1/1999
• Regions of NOD mouse chromosome 17 and chromosome 1 control AICD in the NOD Mouse.
  Bahjat, K.S., Whittaker, D.S., Moldawer, L.L., Clare-Salzler, M.J., etc, Immunology of Diabetes Society Meeting Proceedings, 1/1/1999
• Divergent regulation of IL-12 by PGE2 in monocyte derived dendritic cells.
  Whittaker, D.S., Clare-Salzler M. J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Autoimmunity & Tolerance. Dysregulation of Prostaglandin Synthase 2 (PGS2) in Autoimmunity: IL10 Resistance & STAT5 Regulation.
  Litherland, S.A., Whittaker, D.S., Grebe, K.M., Clare-Salzler, M.J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Defect in AICD in the NOD mouse.
  Bahjat K.S., Bahjat F.R., Whitaker D.S., Xie T., Wakeland E., Auffenberg T., L. L., Moldawer, Clare-Salzler, M.J., Keystone Meeting, Autoimmunity and Tolerance, 1/1/1999
• Immunology of Diabetes Society Conference, Prostaglandin Synthase 2 Expression as a Risk Assessment Tool for IDDM. A New Avenue for Prevention & Intervention?
  Clare-Salzler, M, Immunology of Diabetes Society Proceedings, 1/1/1999
• CPP32 Dysregulation in NOD mice.
  Bahjat, K., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Characterization of monocyte derived dendritic cells (DC) from pre-IDD subjects: Effects of endogenous prostanoids on IL-12 production.
  Whittaker, D.S., Clare-Salzler M.J., Immunology of Diabetes Society Meeting Proceedings, 1/1/1998
• Human monocyte derived dendritic cells (DC) express prostaglandin synthase-2 Impact on DC function.
  Whittaker D.S., Clare-Salzler M.J., Cellular and Molecular Biology of Dendrite Cells. Keystone Symposia on Dendritic Cell Biology, Santa Fe, NM, 1/1/1998
• Aberrant Monocyte Prostaglandin Synthase-2 (PGS-2) expression: A novel cellular marker for IDDM risk.
  Litherland, S.A., Xie, T.X., Whittaker, D.S., Schatz D., Moldawer L.L., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Monocyte Prostaglandin synthase 2 (PGS2) produced prostaglandin E2 (PGE2) inhibits activated T cell IL2 and Il2 receptor alpha (CD25) expression: A mechanism for the l...
  Litherland, S.A., Xie, T.X., Whittaker, D.S., Moldawer L.L., Clare-Salzler M.J., Immunology of Diabetes Society Proceedings, Chicago, IL, 1/1/1998
• Join now to see all

Lectures

• Interferon biology in Type 1 Diabetes 
  Chania, Crete - 1/1/2015
• Nutritional Intervention to Prevent Autoimmune Type 1 Diabetes 
  1/1/2014
• Type 1 Diabetes Immunogenetic-Environmental Interactions on the Pathway to Disease 
  1/1/2014
• Omega-3 fatty acids; Mechanisms of Action and Effects on Inflammatory Disease 
  1/1/2010
• The Role of Type 1 Interferons in Type 1 Diabetes Pathogenesis 
  1/1/2009
• Nutritional Intervention to Prevent Type 1 Diabetes: Progress Report 
  1/1/2008
• Eicosanoid Metabolism in Macrophages; Regulation of Pro-Inflammatory and Resolving Lipid Molecules 
  1/1/2007
• Nutrition, Inflammation, and Type 1 Diabetes 
  University of Florida, College of Medicine - 1/1/2006
• Type 1 IFN in Type 1 Diabetes Pathogenesis; Relationship to Organ Specificity and Disease Acceleration 
  1/1/2005
• Dexamethasone Induces Development of IL-10 Producing Dendritic Cells Derived from Human Monocytes: Implications for Application of These Dendritic Cells for Prevention... 
  Cambridge, England - 1/1/2004
• Abnormal Eicosanoid Metabolism in Type 1 Diabetes: Can we make a Foe an Ally? 
  Baltimore, MD - 1/1/2004
• Resolvin Metabolism and the Pathogenesis of Type 1 Diabetes in the NOD Mouse 
  Cambridge, England - 1/1/2004
• Unique Signature of Stat5B in Regulatory CD4+25+ T Cell 
  Cambridge, England - 1/1/2004
• Eicosanoid and Omega-3 Fatty Acid Mediated Resolution of Inflammation 
  1/1/2003
• Dendritic Cell Biology and the NOD Mouse 
  1/1/2001
• Cox-2 in the Immunopathogenesis of Type-1 Diabetes in Mice and Humans 
  Gainesville, FL - 1/1/1999
• Immunophenotypes/Genotypes Contributing to the Autoimmune Response of NOD Mice 
  1/1/1999
• Immunology of Diabetes Society Meeting, "Aberrant monocyte prostaglandin synthase-2 expression inhibits IL2 and IL2 receptor (CD25) expression in IDD T cells 
  Oak Brook, IL - 1/1/1998
• The Role of PGS2 in Type 1 Diabetes 
  Gainesville, FL - 1/1/1998
• The Neuroendocrine-Immune System 
  1/1/1997
• Cellular Immune Markers and Modeling Risk for Immune Mediated Diabetes 
  1/1/1997
• Tumor Necrosis Factor binding protein (TNF-bp) deuces neutropenia and loss of FAS positive peripheral blood leukocytes in septic baboons 
  Munich, Germany - 1/1/1997
• Regulation of prostaglandin synthase (PGS-2) expression in NOD macrophage. 
  Canberra, Australia - 1/1/1996
• The Role of Prostaglandin Synthase-2 in the Immunopathogenesis of Diabetes in NOD Mice and Pre-Diabetic Humans 
  Gainesville, FL - 1/1/1995
• Dendritic Cell Transfers Protect NOD Mice From Diabetes; Dependence on Islet Antigen Exposure and Modification of Islet Cytokine Profiles of Infiltrating Cell. 
  Taos, NM - 1/1/1995
• Join now to see all